PCM
REPL icon

Pavaki Capital Management’s Replimune Group REPL Stock Holding History

Pavaki Capital Management’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$890K Buy
+80,400
New +$492K 0.31% 58

Other funds holding REPL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Pavaki Capital Management's REPL Position: Q2 2026 in Review

Pavaki Capital Management opened a new position in Replimune Group (REPL) in Q2 2026: 80,400 shares worth $890K. The stake represents 0.31% of the portfolio and ranks #58 among its holdings.

185 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Pavaki Capital Management held 80,400 shares of Replimune Group worth $890K as of Q2 2026.
  • Replimune Group was a new Pavaki Capital Management position in Q2 2026.
  • Replimune Group made up 0.31% of Pavaki Capital Management's portfolio in Q2 2026, its #58 holding.
  • 185 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Pavaki Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.